| #44 |
Carlos J. Bosques |
Momenta Pharmaceuticals |
3 |
| #44 |
Shunsuke Fukagawa |
Schlumberger Technology |
3 |
| #44 |
Emily Hancock |
Gentex |
3 |
| #44 |
Michael Chun-chieh Lee |
Koniniklijke Philips N.V. |
3 |
| #44 |
Jerome P. Moisand |
Juniper Networks |
3 |
| #44 |
Byron DeLaBarre |
Silver Creek Pharmaceuticals |
3 |
| #44 |
Hirotake Mizutani |
Millennium Pharmaceuticals |
3 |
| #44 |
Peter D. Gladstone |
The Boston Beer |
3 |
| #44 |
Lawrence M. Candell |
MIT |
3 |
| #44 |
David C. Duffy |
Quanterix |
3 |
| #44 |
John David Trzupek |
Pfizer |
3 |
| #44 |
Kenneth J. Mandell |
Oyster Point Pharma |
3 |
| #44 |
Paulo C. Lozano |
MIT |
3 |
| #44 |
Howard Sard |
Extend Biosciences |
3 |
| #44 |
Patrick Peralta |
Oracle |
3 |
| #44 |
Kenneth J. Livak |
Applera |
3 |
| #44 |
Deb Kumar Roy |
Bluefin Labs |
3 |
| #44 |
Brian Edward Collins |
Momenta Pharmaceuticals |
3 |
| #44 |
Thomas C. Sobczynski |
Mevion Medical Systems |
3 |
| #44 |
Jeffrey Miles |
Schlumberger Technology |
3 |
| #44 |
Ramin Haghgooie |
The General Hospital |
3 |
| #44 |
Andrew Ziegler |
Kci Licensing |
3 |
| #44 |
Jason W. Sickler |
Quantum-Si Incorporated |
3 |
| #44 |
Imad Jureidini |
Google |
3 |
| #44 |
John Cahalen |
Xtalic |
3 |
| #44 |
Takeru Ehara |
Novartis Ag |
3 |
| #44 |
Damon Weinstein |
Soundbite Communications |
3 |
| #44 |
John Peyton |
IBM |
3 |
| #44 |
David G. Winkler |
Ucb Pharma S.A. |
3 |
| #44 |
Samuel H. Duncan |
NVIDIA |
3 |
| #44 |
Kendra Marchant |
Emc Ip Holding Company |
3 |
| #44 |
Alexander Douglas Perkins |
Boston Dynamics |
3 |
| #44 |
Dylan Charles Bartle |
Skyworks Solutions |
3 |
| #44 |
Todd Hinck |
Intel |
3 |
| #44 |
Liping Yang |
Merck |
3 |
| #44 |
Lukasz Zielinski |
Schlumberger Technology |
3 |
| #44 |
Alia Karin Atlas |
Juniper Networks |
3 |
| #44 |
Ngan Nguyen |
Merck |
3 |
| #44 |
Dan J. Burns |
Mitsubishi Electric |
3 |
| #90 |
Joseph Romano |
Berkshire Grey Operating Company |
2 |
| #90 |
Chad Mikkelson |
Cisco |
2 |
| #90 |
Jonathan Basil Fitzgerald |
Ipsen Biopharm Limited |
2 |
| #90 |
Oliver P. Peoples |
Metabolix |
2 |
| #90 |
Daniel M. Hartmann |
Idex Health & Science |
2 |
| #90 |
Kwok-Kin Wong |
Dana-Farber Cancer Institute |
2 |
| #90 |
Douglas Warren Young |
Bose |
2 |
| #90 |
Amy Elder |
Millennium Pharmaceuticals |
2 |
| #90 |
Kevin Groves |
Visen Medical |
2 |
| #90 |
Steven G. Johnson |
MIT |
2 |
| #90 |
Nan Ji |
Kymera Therapeutics |
2 |